Booth BP - Search Results

1

Use of patient-reported outcomes (PRO) data to complement exposure-response analysis in early clinical cancer drug development.

Xia H, Booth BP, Wang Y, Fan C, Bhatnagar V, Kluetz P, Fourie Zirkelbach J. Xia H, et al. Among authors: booth bp. J Patient Rep Outcomes. 2023 Nov 17;7(1):116. doi: 10.1186/s41687-023-00651-2. J Patient Rep Outcomes. 2023. PMID: 37975967 Free PMC article.

2

Land O'Lakes Workshop on Microsampling: Enabling Broader Adoption.

Wickremsinhe ER, Ji QC, Gleason CR, Anderson M, Booth BP. Wickremsinhe ER, et al. Among authors: booth bp. AAPS J. 2020 Oct 23;22(6):135. doi: 10.1208/s12248-020-00524-2. AAPS J. 2020. PMID: 33098040 Free PMC article.

3

Current Perspectives on Ligand-Binding Assay Practices in the Quantification of Circulating Therapeutic Proteins for Biosimilar Biological Product Development.

Thway TM, Wang YM, Booth BP, Maxfield K, Huang SM, Zineh I. Thway TM, et al. Among authors: booth bp. AAPS J. 2019 Dec 19;22(1):15. doi: 10.1208/s12248-019-0397-8. AAPS J. 2019. PMID: 31858313

4

Modelling the impacts of climate change on riverine thermal regimes in western Canada's largest Pacific watershed.

Islam SU, Hay RW, Déry SJ, Booth BP. Islam SU, et al. Among authors: booth bp. Sci Rep. 2019 Aug 6;9(1):11398. doi: 10.1038/s41598-019-47804-2. Sci Rep. 2019. PMID: 31388033 Free PMC article.

5

Model-informed drug development approach supporting approval of the 4-week (Q4W) dosing schedule for nivolumab (Opdivo) across multiple indications: a regulatory perspective.

Bi Y, Liu J, Furmanski B, Zhao H, Yu J, Osgood C, Ward A, Keegan P, Booth BP, Rahman A, Wang Y. Bi Y, et al. Among authors: booth bp. Ann Oncol. 2019 Apr 1;30(4):644-651. doi: 10.1093/annonc/mdz037. Ann Oncol. 2019. PMID: 30715147 Free article.

6

Hybrid assays: the next big thing?

Booth BP, Furmanski B. Booth BP, et al. Bioanalysis. 2018 Jul 1;10(13):975-977. doi: 10.4155/bio-2018-0123. Epub 2018 Jul 11. Bioanalysis. 2018. PMID: 29993267 Free article. No abstract available.

7

Time dependent pharmacokinetics of pembrolizumab in patients with solid tumor and its correlation with best overall response.

Li H, Yu J, Liu C, Liu J, Subramaniam S, Zhao H, Blumenthal GM, Turner DC, Li C, Ahamadi M, de Greef R, Chatterjee M, Kondic AG, Stone JA, Booth BP, Keegan P, Rahman A, Wang Y. Li H, et al. Among authors: booth bp. J Pharmacokinet Pharmacodyn. 2017 Oct;44(5):403-414. doi: 10.1007/s10928-017-9528-y. Epub 2017 Jun 1. J Pharmacokinet Pharmacodyn. 2017. PMID: 28573468

8

Association of time-varying clearance of nivolumab with disease dynamics and its implications on exposure response analysis.

Liu C, Yu J, Li H, Liu J, Xu Y, Song P, Liu Q, Zhao H, Xu J, Maher VE, Booth BP, Kim G, Rahman A, Wang Y. Liu C, et al. Among authors: booth bp. Clin Pharmacol Ther. 2017 May;101(5):657-666. doi: 10.1002/cpt.656. Epub 2017 Mar 22. Clin Pharmacol Ther. 2017. PMID: 28182273

9

Meeting report: metabolites in safety testing (MIST) symposium-safety assessment of human metabolites: what's REALLY necessary to ascertain exposure coverage in safety tests?

Gao H, Jacobs A, White RE, Booth BP, Obach RS. Gao H, et al. Among authors: booth bp. AAPS J. 2013 Oct;15(4):970-3. doi: 10.1208/s12248-013-9502-6. Epub 2013 Jul 3. AAPS J. 2013. PMID: 23821354 Free PMC article.

10

Conference report: emerging technology for bioanalysis in the next decade.

Demuth JE, Ji QC, Booth BP, Fluhler EN, Greathead R, Ho S, Stubbs RJ, Turk DJ. Demuth JE, et al. Among authors: booth bp. Bioanalysis. 2012 Nov;4(21):2557-61. doi: 10.4155/bio.12.227. Bioanalysis. 2012. PMID: 23173791 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

40 results

Search Page